These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2766740)

  • 1. Peritonitis prevention in CAPD by intraperitoneal IgG.
    Lamperi S; Carozzi S
    Contrib Nephrol; 1989; 70():325-9. PubMed ID: 2766740
    [No Abstract]   [Full Text] [Related]  

  • 2. Can the risk of peritonitis be predicted for new continuous ambulatory peritoneal dialysis (CAPD) patients?
    Coles GA; Minors SJ; Horton JK; Fifield R; Davies M
    Perit Dial Int; 1989; 9(1):69-72. PubMed ID: 2488186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritonitis prevention in CAPD.
    Carozzi S; Lamperi S
    Clin Nephrol; 1988; 30 Suppl 1():S45-8. PubMed ID: 3141093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis.
    Coban E; Ozdogan M; Tuncer M; Bozcuk H; Ersoy F
    J Nephrol; 2004; 17(3):427-30. PubMed ID: 15365965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of peritonitis in APD versus CAPD: methodologic problems.
    Nessim SJ; Bargman JM
    Nephrol Dial Transplant; 2008 May; 23(5):1769-70; author reply 1770. PubMed ID: 18156456
    [No Abstract]   [Full Text] [Related]  

  • 6. [Continuous ambulatory peritoneal dialysis--current concepts after 10 years' experience].
    Rottembourg J; Babronski C
    Ther Umsch; 1988 Dec; 45(12):900-7. PubMed ID: 3065971
    [No Abstract]   [Full Text] [Related]  

  • 7. Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies.
    Gokal R; Ramos JM; Francis DM; Ferner RE; Goodship TH; Proud G; Bint AJ; Ward MK; Kerr DN
    Lancet; 1982 Dec; 2(8312):1388-91. PubMed ID: 6129474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis (CAPD).
    Schröder CH; Bakkeren JA; Weemaes CM; Monnens LA
    Perit Dial Int; 1989; 9(4):261-5. PubMed ID: 2488378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis (Part 1): Continuous ambulatory peritoneal dialysis (continuing education credit).
    Macdonald J
    Nurs Stand; 1997 Feb; 11(22):48-53; quiz 54-5. PubMed ID: 9096512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors associated with peritonitis among patients on continuous ambulatory peritoneal dialysis (CAPD).
    Steinberg SM; Cutler SJ; Novak JW; Nolph KD
    Trans Am Soc Artif Intern Organs; 1985; 31():565-7. PubMed ID: 3837508
    [No Abstract]   [Full Text] [Related]  

  • 12. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
    Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
    Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida peritonitis in 2 patients on continuous ambulatory peritoneal dialysis (CAPD).
    Bozkurt F; Keller E; Schollmeyer P; Kappe R; Müller J
    Mycoses; 1988; Suppl 1():69-74. PubMed ID: 3252163
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
    Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteroides peritonitis associated with colon cancer in a continuous ambulatory peritoneal dialysis patient.
    Nachimuthu S; Visconti EB; Pannone JB; Kaneb GC; Simonian H; Aung Z; Gopal L
    South Med J; 2001 Oct; 94(10):1021-2. PubMed ID: 11702814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Campylobacter jejuni peritonitis and bacteremia in a patient undergoing continuous ambulatory peritoneal dialysis.
    Lang CL; Chiang CK; Hung KY; Wu KD
    Clin Nephrol; 2009 Jan; 71(1):96-8. PubMed ID: 19203559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous ambulatory peritoneal dialysis (CAPD)--ten years on.
    Gokal R
    Q J Med; 1987 Jun; 63(242):465-72. PubMed ID: 3310075
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of peritoneal dialysate IgG levels in CAPD patients.
    De Vecchi A; Castelnovo C; Failla N; Scalamogna A
    Adv Perit Dial; 1990; 6():98-101. PubMed ID: 1982850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonococcal peritonitis in a patient treated with continuous ambulatory peritoneal dialysis (CAPD).
    Wolfson AB; Nachamkin I; Singer I; Moffitt CM; Buchan AM
    Am J Kidney Dis; 1985 Oct; 6(4):257-60. PubMed ID: 4050785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritonitis caused by Candida lusitaniae in patient on continuous ambulatory peritoneal dialysis (CAPD).
    García-Martos P; Díaz J; Castaño M; Pérez M; Marín P
    Clin Nephrol; 1991 Jul; 36(1):50. PubMed ID: 1889152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.